Lung diseases like tuberculosis and cystic fibrosis can be difficult to treat. In part, that's because the two-dimensional models researchers use to study the diseases don't accurately reflect the ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the ...

Accurate Lung cancer (LC) identification is a big medical problem in the AI-based healthcare systems. Various deep learning-based methods have been proposed for Lung cancer diagnosis. In this study, ...

UCLA researchers have created the first lung organoids with organotypic blood vessel networks, marking a major advancement in modeling how lungs naturally develop in the human body. The vascularized ...

Biological assailants like fungi, bacteria, and viruses continuously test natural defenses that have evolved over millennia. Newer and stranger particles that originate from burning fuels, harmful ...

Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary disease characterized by fibrotic lesions, with excessive deposition of extracellular matrix (ECM) and destruction of the lung ...

A method has been reported by researchers from Tsinghua University in China, which enables the efficient and high-throughput production of lung cancer assembloids. These assembloids are ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...